SCHEMBL7759073

SCHEMBL7759073

NC(=O)CCc1nc(-c2ccccc2)nc2ccccc12

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRNP P04156 4/20 0.60
SIRT5 Q9NXA8 1/20 0.49
PDE10A Q9Y233 1/20 0.48
L3MBTL1 Q9Y468 3/20 0.47
KDM4E B2RXH2 1/20 0.47
ABCG2 Q9UNQ0 3/20 0.47
ADORA3 P0DMS8 1/20 0.47
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
HCRTR1 O43613 1/20 0.46
CYP1A2 P05177 1/20 0.45
POLB P06746 1/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
RXFP1 Q9HBX9 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
TSHR P16473 1/20 0.45
MAPT P10636 1/20 0.45
NR4A2 P43354 1/20 0.45
TSPO P30536 3/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10674022 0.88 SIRT5 (0.58) PRNPSIRT5L3MBTL1KDM4EABCG2
SCHEMBL13502532 0.85 PRNP (0.59) PRNPSIRT5PDE10AL3MBTL1KDM4E
SCHEMBL10677871 0.80 PRNP (0.65) PRNPL3MBTL1KDM4EMEN1KMT2A
SCHEMBL10680979 0.80 TSPO (0.57) PRNPSIRT5L3MBTL1KDM4EABCG2
SCHEMBL10675164 0.79 CYP1A2 (0.52) PRNPSIRT5PDE10AL3MBTL1KDM4E
SCHEMBL10679424 0.79 HPGD (0.53) PRNPSIRT5L3MBTL1KDM4EABCG2
SCHEMBL10670717 0.78 NAAA (0.53) L3MBTL1KDM4EMEN1KMT2ARXFP1
SCHEMBL10506199 0.77 NR4A2 (0.43) PRNPSIRT5PDE10AL3MBTL1KDM4E
SCHEMBL1085568 0.77 MEN1 (0.49) PRNPL3MBTL1ABCG2MEN1KMT2A
SCHEMBL10673338 0.75 HTT (0.56) L3MBTL1KDM4EABCG2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1087790-A2 USE OF A COMPOUND HAVING AFFINITY FOR THE BENZODIAZEPINE MITOCHONDRIAL RECEPTOR IN CANCER THERAPY CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2001-04-04 EP claimed
WO-1999066958-A2 USE OF A COMPOUND HAVING AFFINITY FOR THE BENZODIAZEPINE MITOCHONDRIAL RECEPTOR IN CANCER THERAPY CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 1999-12-29 WO claimed
US-6319931-B1 APOPTOSIS-INDUCING AGENT FOR CANCER TREATMENT CENTRE NATIONAL DE AL RECHERCHE SCIENTIFIQUE (CNRS) (FR) 2001-11-20 US disclosed
EP-1087790-A2 USE OF A COMPOUND HAVING AFFINITY FOR THE BENZODIAZEPINE MITOCHONDRIAL RECEPTOR IN CANCER THERAPY CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2001-04-04 EP disclosed
WO-1999066958-A2 USE OF A COMPOUND HAVING AFFINITY FOR THE BENZODIAZEPINE MITOCHONDRIAL RECEPTOR IN CANCER THERAPY CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 1999-12-29 WO disclosed
EP-0210084-B1 AMIDES, PROCESSES FOR THEIR PREPARATION AND MEDICAMENTS CONTAINING THEM RHONE-POULENC SANTE (FR) 1989-02-08 EP disclosed
EP-0210084-A1 Amides, processes for their preparation and medicaments containing them RHONE-POULENC SANTE (FR) 1987-01-28 EP disclosed